Nerviano Medical Sciences to present data on novel anticancer molecules at the AACR Annual Meeting 2013
Nerviano, Mar 6, 2013 – Nerviano Medical Sciences will disclose data on novel anticancer molecules at the AACR Annual Meeting 2013.The presentations include:Ardini, E et al: “Identification of a highly potent, selective and orally available RET inhibitor with antitumor efficacy in RET-dependent tumor models”. Abstract Number: 2091 Presentation Time: Monday, Apr 08, 2012, 1:00 PM - 5:00...
Read more
Oncology
We fight cancer. Our mission is to identify innovative agents for clinical development in areas of unmet